The Risk of Dystonia among Children and Adolescents Treated with Atomoxetine within the Truven MarketScan Database (B4Z-MC-B031)

24/03/2016
31/03/2024
EU PAS number:
EUPAS11221
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data source(s), other

Truven Health Analytics MarketScan®

Data sources (types)

Administrative healthcare records (e.g., claims)
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No